Lamictal and Ataxia aggravated - a phase IV clinical study of FDA data
Ataxia aggravated is found among people who take Lamictal, especially for people who are female, 50-59 old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Lamictal and have Ataxia aggravated. It is created by eHealthMe based on reports of 69,354 people who have side effects when taking Lamictal from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
69,354 people reported to have side effects when taking Lamictal.
Among them, 394 people (0.57%) have Ataxia aggravated.
What is Lamictal?
Lamictal has active ingredients of lamotrigine. It is often used in bipolar disorder. eHealthMe is studying from 77,163 Lamictal users for its effectiveness, alternative drugs and more.
What is Ataxia aggravated?
Ataxia aggravated (serious loss of full control of bodily movements) is found to be associated with 915 drugs and 340 conditions by eHealthMe.
Number of Lamictal and Ataxia aggravated reports submitted per year:
Time on Lamictal when people have Ataxia aggravated *:
Gender of people who have Ataxia aggravated when taking Lamictal*:
Age of people who have Ataxia aggravated when taking Lamictal *:
Common drugs people take besides Lamictal *:
Common side effects people have besides Ataxia aggravated *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Lamictal and have Ataxia aggravated?Check whether Ataxia aggravated is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Alonso-Navarro H, Montes JM, Plaza-Nieto JF, Jiménez-Jiménez FJ, "Cataplexy Possibly Associated With Lamotrigine", Journal of clinical psychopharmacology, 2016 Aug .
- Gupta MC, Khanna J, Mathur R, Mittal N, "Lamotrigine-induced fulminant hepatic failure: an unusual presentation", IMSEAR, 2015 Jan .
How severe was Ataxia aggravated and when was it recovered:
Expand to all the drugs that have ingredients of lamotrigine:
Alternative drugs to, pros and cons of Lamictal:
- Lamictal (77,163 reports)
Common Lamictal side effects:
Browse all side effects of Lamictal:a b c d e f g h i j k l m n o p q r s t u v w x y z
Ataxia aggravated treatments and more:
- Ataxia aggravated (6 reports)
COVID vaccines that are related to Ataxia aggravated:
- Ataxia aggravated in Moderna COVID Vaccine
- Ataxia aggravated in Pfizer BioNTech Covid Vaccine
- Ataxia aggravated in Johnson and Johnson Covid Vaccine
Common drugs associated with Ataxia aggravated:
All the drugs that are associated with Ataxia aggravated:
- Ataxia aggravated (915 drugs)
Common conditions associated with Ataxia aggravated:
All the conditions that are associated with Ataxia aggravated:
- Ataxia aggravated (340 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on lamotrigine (the active ingredients of Lamictal) and Lamictal (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Elavil and Geodon drug interaction - 2 seconds ago
- Klor-Con and Mobility Decreased - 3 seconds ago
- Losartan Potassium vs. Maxzide - 4 seconds ago
- Cyclophosphamide and Retching - 4 seconds ago
- Mycobacterial Infection and drugs of ingredients of rituximab - 18 seconds ago
- Doxycycline Hyclate and Hypoglycaemia Aggravated - 18 seconds ago
- Cortef and Saphris drug interaction - 20 seconds ago
- Amaryl and Eye Swelling - 26 seconds ago
- Lisinopril and Mean Cell Haemoglobin Decreased - 27 seconds ago
- Taltz and Oxycontin drug interaction - 32 seconds ago